Literature DB >> 10223571

Malignant fibrous histiocytoma of the extremity.

J C Salo1, J J Lewis, J M Woodruff, D H Leung, M F Brennan.   

Abstract

BACKGROUND: This study examines prognostic factors and outcomes for a group of patients with malignant fibrous histiocytoma of the extremity treated at a single referral institution.
METHODS: A total of 239 patients underwent complete surgical excision between July 1982 and July 1996 and were followed prospectively.
RESULTS: The overall 5-year and 10-year disease specific survival rates for this group were 65% and 59%, respectively. Age >50 years, tumor location, and presentation with local recurrence were all associated with increased risk of local recurrence. Tumor size, grade, depth, and presentation with local recurrence were all associated with adverse disease specific and metastasis free survival. Tumor size > or = 10 cm was associated with a particularly unfavorable outcome.
CONCLUSIONS: The majority of malignant fibrous histiocytomas of the extremity are associated with a relatively favorable prognosis. Size > or = 5 cm, deep depth, and high grade are all unfavorable factors. Size > or = 10 cm is associated with an even more unfavorable prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10223571

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

Review 1.  Malignant fibrous histiocytoma: past, present, and future.

Authors:  A E Rosenberg
Journal:  Skeletal Radiol       Date:  2003-09-27       Impact factor: 2.199

2.  Soft-tissue malignant fibrous histiocytoma (high-grade undifferentiated pleomorphic sarcoma) arising in a desmoid tumor in a patient with Milroy's disease.

Authors:  Mary I O'Connor; Mark J Kransdorf; David M Menke
Journal:  Skeletal Radiol       Date:  2006-01-25       Impact factor: 2.199

3.  Clinical report on transarterial neoadjuvant chemotherapy of malignant fibrous histiocytoma in soft tissue.

Authors:  Jun Guo; Qiu Cui; Cheng Liu; Jiahong Sui; Ning Jiang; Ju Zhou; Dingfeng Li; Yanjun Zeng
Journal:  Clin Transl Oncol       Date:  2012-09-14       Impact factor: 3.405

4.  Acute Trauma Precipitating the Onset of Chest Wall Myxofibrosarcoma.

Authors:  Kyle D Klingbeil; Sameera S Vangara; Raymond M Fertig; Jason L Radick
Journal:  Indian J Surg Oncol       Date:  2018-06-20

5.  Importance of tumor size in soft tissue sarcomas: a proposal for a nomogram based on a score system to staging soft tissue sarcomas in the postoperative setting.

Authors:  Rosa Angélica Salcedo Hernández; Leonardo Saúl Lino-Silva; David Cantú de León; Ángel Herrera-Gómez; Héctor Martínez-Said; Abelardo Meneses-García
Journal:  Med Oncol       Date:  2014-02-04       Impact factor: 3.064

6.  Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.

Authors:  Jacob Engellau; Annette Persson; Pär-Ola Bendahl; Måns Akerman; Henryk A Domanski; Bodil Bjerkehagen; Peer Lilleng; Johan Weide; Anders Rydholm; Thor A Alvegård; Mef Nilbert
Journal:  Virchows Arch       Date:  2004-08-07       Impact factor: 4.064

7.  Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

Authors:  Rosario Gil-Benso; Javier Megías; Teresa San-Miguel; Sandra Pinto; Robert C Callaghan; Concha López-Ginés; Miguel Cerdá-Nicolás
Journal:  Cytotechnology       Date:  2017-07-04       Impact factor: 2.058

8.  Head and Neck Tumors: Management of Primary Undifferentiated Pleomorphic Sarcoma.

Authors:  Luis-Alejandro Boccalatte; Natalia-Lucía Gómez; Alejandro Yanzon; Eduardo-Luis Mazzaro; Federico Cayol; Marcelo-Fernando Figari
Journal:  Iran J Otorhinolaryngol       Date:  2019-11

9.  Managing soft tissue sarcomas in a developing country: are prognostic factors similar to those of developed world?

Authors:  Irfan Qadir; Masood Umer; Hafiz Muhammad Umer; Nasir Uddin; Farrok Karsan; Muhammad Sharoz Rabbani
Journal:  World J Surg Oncol       Date:  2012-09-13       Impact factor: 2.754

10.  Recurrence of atypical fibroxanthoma. Diagnosis and treatment.

Authors:  Leandro Ricardo Mattiola; Lyzandro Mattiola; Giovani Mattiola; Sandra Zucchi de Moraes Mattiola; Carlos Eduardo Moura; Alexandre Kirschnick
Journal:  Int Arch Otorhinolaryngol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.